19th Jan 2009 17:41
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares purchased at a price of £12.53 per share on 15 January 2009, and Ordinary share ADRs purchased at a price of $39.43 per ADR on 12 January 2009 in GlaxoSmithKline plc, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 8 January 2009.
|
Ordinary shares |
ADRs |
|
|
Mr A P Witty |
224.23 |
|
|
Mr J S Heslop |
0.01 |
|
|
Dr M M Slaoui |
65.45 |
|
|
Mrs C E Bruck Slaoui |
20.43 |
|
|
Mr S M Bicknell |
29.20 |
|
|
Mr J M Clarke |
139.42 |
|
|
Mr M Dunoyer |
84.45 |
|
|
Mr E J Gray |
84.75 |
|
|
Mr D Learmouth |
0.01 |
|
|
Mr W C Louv |
44.55 |
|
|
Mr D J Phelan |
135.99 |
|
|
Dr D Pulman |
78.67 |
|
|
Mr D S Redfern |
0.38 |
|
|
Ms C Thomas |
0.74 |
|
|
Mr J R Stéphenne |
236.31 |
The Company was advised of this information on 19 January 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
19 January 2009
Related Shares:
Glaxosmithkline